2. You allocate to global, active public equity (including long‑short) across developed and emerging markets and benchmark to global indices.
Our mandate is global with dedicated emerging markets capability and an active, research‑driven approach that can be measured against MSCI ACWI and equity-hedge benchmarks.
4. You emphasize stock‑selection alpha and beating both your composite and the simple 70/30 benchmark.
Our high‑conviction, bottom‑up process targets idiosyncratic alpha with low benchmark overlap, aiming to exceed ACWI and add value over a 70/30 proxy through cycle.